Investigating the Effect of High-Dose Vitamin D3 Administration on Inflammatory Biomarkers in Patients with Moderate to Severe Traumatic Brain Injury: A Randomized Clinical Trial.
Administration of high-dose vitamin D3 in the acute phase of TBI could be effective in lowering the inflammatory markers and improving the level of consciousness and long-term performance outcomes.<b>Trial Registration Number:</b> IRCT20180522039777N2.
Authors
- Saied Amniati (ORCID: https://orcid.org/0000-0002-2128-2540)
- Farnoosh Masbough (ORCID: https://orcid.org/0000-0003-0983-3642)
- Mohammad Sistanizad (ORCID: https://orcid.org/0000-0002-7836-6411)
- Mohsen Koosha (ORCID: https://orcid.org/0000-0002-1660-3178)
- Mir Mohammad Miri (ORCID: https://orcid.org/0000-0003-3918-6802)
- Masoomeh Raoufi (ORCID: https://orcid.org/0000-0001-7269-1822)
- Mehran Kouchek (ORCID: https://orcid.org/0000-0002-2070-9856)
- Sara Salarian (ORCID: https://orcid.org/0000-0002-4544-8883)
- Niloufar Taherpour (ORCID: https://orcid.org/0000-0002-8336-0671)
Institutions
- Imam Hossein Hospital (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.30476/ijms.2023.99465.3156
- Citations
- 4
- Primary Topic
- Vitamin C and Antioxidants Research
- Type
- article
- Field-Weighted Citation Impact
- 1.24
Funders
- Shahid Beheshti University of Medical Sciences